Max Berger
No más puestos en curso
Perfil
Max Berger worked as the Director-Legal Affairs at Dagris SA from 2001 to 2007.
He also worked as an Independent Director at rEVO Biologics, Inc. from 2014 to 2015.
Prior to that, he was the Executive Vice-President & Legal Affairs at Laboratoire Français du Fractionnement et des Biotechnologies.
Mr. Berger graduated from Université Paris Nanterre with a degree.
Antiguos cargos conocidos de Max Berger.
| Empresas | Cargo | Fin |
|---|---|---|
Dagris SA
 Dagris SA Agricultural Commodities/MillingProcess Industries Dagris SA operates as a holding company with interest in financing and developing agricultural projects like cotton and seed oil farming. The firm is engaged in processing cotton and produces fiber. The company's processing activities include drying, pre-cleaning and ginning of cotton. It is headquartered in Paris, France. | Consejero General | 01/01/2007 |
Laboratoire Français du Fractionnement et des Biotechnologies
 Laboratoire Français du Fractionnement et des Biotechnologies BiotechnologyHealth Technology Laboratoire Francais du Fractionnement et des Biotechnologies SA provides plasma-derived medicinal products. It undertakes research and development programs in plasma fractions and biotechnologies in the areas of autoimmune diseases and hemostasis disorders. The firm's products include albumin and immunoglobulin. It also offers products for rare pathologies. The company was founded in 1994 and is headquartered in Les Ulis, France. | Corporate Officer/Principal | - |
| REVO BIOLOGICS INC | Director/Miembro de la Junta | - |
Formación de Max Berger.
| Université Paris Nanterre | Graduate Degree |
Experiencias
Funciones ocupadas
Empresas relacionadas
| Empresas privadas | 3 |
|---|---|
Dagris SA
Dagris SA Agricultural Commodities/MillingProcess Industries Dagris SA operates as a holding company with interest in financing and developing agricultural projects like cotton and seed oil farming. The firm is engaged in processing cotton and produces fiber. The company's processing activities include drying, pre-cleaning and ginning of cotton. It is headquartered in Paris, France. | Process Industries |
rEVO Biologics, Inc.
 rEVO Biologics, Inc. BiotechnologyHealth Technology rEVO Biologics, Inc. engages in the development and commercialization of specialty therapeutics to address unmet medical needs in patients with rare, life-threatening conditions. Its products include ATryn, which prevents blood clots during and after surgery and childbirth for patients with hereditary antithrombin deficiency. The company was founded in February 1993 and is headquartered in Framingham, MA. | Health Technology |
Laboratoire Français du Fractionnement et des Biotechnologies
Laboratoire Français du Fractionnement et des Biotechnologies BiotechnologyHealth Technology Laboratoire Francais du Fractionnement et des Biotechnologies SA provides plasma-derived medicinal products. It undertakes research and development programs in plasma fractions and biotechnologies in the areas of autoimmune diseases and hemostasis disorders. The firm's products include albumin and immunoglobulin. It also offers products for rare pathologies. The company was founded in 1994 and is headquartered in Les Ulis, France. | Health Technology |
- Bolsa de valores
- Insiders
- Max Berger